沃森生物: 第五届董事会第二十九次会议决议公告

Group 1 - The company held its 29th meeting of the 5th Board of Directors on June 16, 2025, via telecommunication, with all 10 directors present [1][2] - The board approved the appointment of Li Wei and Liu Yuran as vice presidents, aiming to enhance the company's core competitiveness and align with national high-quality development goals [1][2] - Liu Yuran submitted his resignation as the board secretary during the meeting, and the board designated Chairman Li Yunchun to act as the interim board secretary until a new appointment is made [2][3] Group 2 - The board proposed to appoint Yan Ye as the new board secretary, pending his acquisition of the necessary qualifications [2][3] - The appointments of Li Wei and Liu Yuran are part of the company's strategy to build a professional, youthful, international, and "Walvax" team [1][2] - The board's decisions were unanimously approved with 10 votes in favor, indicating strong support for the management changes [2][3] Group 3 - Li Wei has a strong background in organic small molecule and polymer synthesis, with experience in vaccine industrialization and multiple national projects [4][5] - Liu Yuran has held various significant roles in investment banking and corporate governance, contributing to major asset restructuring and investor relations [5][6] - Yan Ye has extensive experience in capital operations and legal compliance, making him a suitable candidate for the board secretary position [6]